arrow
D

David Feifel

kadima neuropsychiatry institute
H指数:46
被引数:8,844

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrating evidence, subject-matter expertise, and consensus in Delphi-based clinical guideline development

整合证据、专业知识和共识在基于德尔菲法的临床指南开发中的应用

2026-07-010
PRE
Interdisciplinary, delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American society of ketamine physicians, psychotherapists, and practitioners (ASKP3)

美国氯胺酮医师、心理治疗师和实践者学会(ASKP3)关于静脉氯胺酮输注治疗抑郁障碍的跨学科、德尔菲驱动共识指南

2026-05-160
OAAI
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis

治疗性联盟在psilocybin治疗难治性抑郁症中的作用:一项事后路径分析

2026-03-230
PRE
Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds

临床试验参与者在经典迷幻药研究中的挑战: 国家抑郁症中心网络关于迷幻药和相关化合物的工作组的立场声明

2026-02-050
PRE
Corrigendum to “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression” [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]

勘误:“致幻体验在抗抑郁药难治性抑郁症的裸盖菇素治疗中的作用”[情感障碍杂志,卷372(2025),第523-532页]

2025-10-100
PRE
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression

迷幻经验在psilocybin治疗难治性抑郁症中的作用

2025-03-011
PRE
Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology

经美国抑郁症中心国家网络、临床经颅磁刺激学会及国际临床神经生理学联合会联合endorse的关于经颅磁刺激治疗抑郁症的共识性评述与思考:全面更新

2025-02-010
OAAI
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

单剂量裸盖菇素治疗难治性抑郁症: 对患者报告的抑郁症严重程度,焦虑,功能和生活质量的影响

2023-04-0176
OAAI
Pursuing personalized medicine for depression by targeting the lateral or medial prefrontal cortex with Deep TMS

通过深TMS靶向外侧或内侧前额叶皮层寻求抑郁症的个性化药物

2023-02-2215
OA
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

单剂量Psilocybin治疗重度抑郁症的难治性发作

2022-11-03403
OA
Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial
2021-11-0152
PREAI
Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial
2021-09-09105
OAAI